Viscosupplementation Market To Witness A Significant Growth Of USD 9.14 Billion By 2030
![Image](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEik9CXdZgrx-EBCeHgvTwwHJkn9yLPY6ihdLlJ7vUy5-oQyzIVS2KkpdaBHwXqg4CxNG5hoOOH1Plh0ZthMNfL8N5ELgcwihev15HpkpR91JonzmcOSGFPBpL0XrylfPsal-p4eiBHqaxsVkZH0NbMt_zcagBhO6LZGt0A134fpjw1rexR-Fix5MTR3jLLo/s320/Viscosupplementation%20Market.png)
San Francisco, 31 Jan 2024: The Report Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single Injection, Three Injection, Five Injection), By End-use (Hospitals, Orthopedic Clinics/ASCs), By Region (Asia Pacific, Europe), And Segment Forecasts, 2023 - 2030 The global viscosupplementation market size is expected to reach USD 9.14 billion by 2030 and is expected to grow at a CAGR of 9.58% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth is driven by several key factors, including a rise in the elderly population, an increase in osteoarthritis cases among older individuals, and substantial investments in research and development. According to the CDC, approximately 25% of adults in the United States currently experience some type of arthritis, and this number is expected to reach 78 million by 2040. As a result, the demand for viscosupplementation is predicted to surge in the coming years. Furthermore, the ma